On 11 January 2011, EFSA published a Scientific Opinion on the revision of the quantitative risk assessment of the BSE risk posed by processed animal proteins [EFSA Journal 2011; 9(1):1947.] (‘EFSA's 2011 opinion’). This scientific opinion indicates that 90 % of the total infectivity amount in a BSE clinical case is associated with central and peripheral nervous system tissues. More precisely, this opinion estimated that 65 % of the total amount of infectivity in a clinical case of BSE is associated with the brain and 26 % is associated with the spinal cord.
Recital 8, Regulation (EU) 2015/1162
In forcesince 15 Jul 2015